Cases & Deals

Cytheris places shares with investor group

Clients Cytheris S.A.

Jones Day advised Cytheris S.A., a privately held clinical-stage biopharmaceutical company, in connection with its issuance of €24.3 million ($30.7 million) of Series B Convertible Preferred Stock in a private placement to CDC Enterprises Innovation, ABN AMRO Capital Life Sciences, AXA Private Equity, BIOAM/Bioamgestion, Crédit Agricole Private Equity, T2C2/Bio 2000, and Caisse de Dépôt et Placement du Québec.